flecainide has been researched along with Cardiomyopathy, Congestive in 7 studies
Flecainide: A potent anti-arrhythmia agent, effective in a wide range of ventricular and atrial ARRHYTHMIAS and TACHYCARDIAS.
flecainide : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 2,5-bis(2,2,2-trifluoroethoxy)benzoic acid with the primary amino group of piperidin-2-ylmethylamine. An antiarrhythmic agent used (in the form of its acetate salt) to prevent and treat tachyarrhythmia (abnormal fast rhythm of the heart).
| Excerpt | Relevance | Reference |
|---|---|---|
| "A 72-year-old male patient with dilated cardiomyopathy was treated with oral flecainide (100 mg/day) for persistent atrial fibrillation (AF) that could not be converted to sinus rhythm by electrical cardioversion." | 7.74 | Impact of serum flecainide level on control of atrial fibrillation in a case treated with cardiac resynchronization therapy. ( Aonuma, K; Doki, K; Homma, M; Kawano, S; Kohda, Y; Kuga, K; Yamaguchi, I, 2007) |
| "A 72-year-old male patient with dilated cardiomyopathy was treated with oral flecainide (100 mg/day) for persistent atrial fibrillation (AF) that could not be converted to sinus rhythm by electrical cardioversion." | 3.74 | Impact of serum flecainide level on control of atrial fibrillation in a case treated with cardiac resynchronization therapy. ( Aonuma, K; Doki, K; Homma, M; Kawano, S; Kohda, Y; Kuga, K; Yamaguchi, I, 2007) |
| "Amiodarone has a more favourable therapeutic profile than flecainide and propafenone in these patients, having less tendency to worsen heart failure." | 2.67 | A multicentre, randomized trial on the benefit/risk profile of amiodarone, flecainide and propafenone in patients with cardiac disease and complex ventricular arrhythmias. Antiarrhythmic Drug Evaluation Group (A.D.E.G.). ( , 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (28.57) | 18.7374 |
| 1990's | 3 (42.86) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sekine, M | 1 |
| Masutani, S | 1 |
| Imamura, T | 1 |
| Iwamoto, Y | 1 |
| Muraji, S | 1 |
| Yoshiba, S | 1 |
| Ishido, H | 1 |
| Sumitomo, N | 1 |
| Doki, K | 1 |
| Homma, M | 1 |
| Kuga, K | 1 |
| Kawano, S | 1 |
| Aonuma, K | 1 |
| Yamaguchi, I | 1 |
| Kohda, Y | 1 |
| Krishnan, SC | 1 |
| Josephson, ME | 1 |
| Brakhmann, I | 1 |
| Shmitt, K | 1 |
| Baĭer, T | 1 |
| Valdeker, B | 1 |
| Khilbel, T | 1 |
| Kiubler, V | 1 |
| Gladman, G | 1 |
| Wilkinson, JL | 1 |
| Evans-Jones, G | 1 |
| Goedel-Meinen, L | 1 |
| Hofmann, M | 1 |
| Schmidt, G | 1 |
| Barthel, P | 1 |
| Baedeker, W | 1 |
| Blömer, H | 1 |
2 trials available for flecainide and Cardiomyopathy, Congestive
| Article | Year |
|---|---|
A multicentre, randomized trial on the benefit/risk profile of amiodarone, flecainide and propafenone in patients with cardiac disease and complex ventricular arrhythmias. Antiarrhythmic Drug Evaluation Group (A.D.E.G.).
Topics: Amiodarone; Cardiomyopathy, Dilated; Cardiomyopathy, Hypertrophic; Dose-Response Relationship, Drug; | 1992 |
[Effect of class I anti-arrhythmia agents on the signal-averaged ECG].
Topics: Anti-Arrhythmia Agents; Cardiomyopathy, Dilated; Clinical Trials as Topic; Coronary Disease; Disopyr | 1988 |
5 other studies available for flecainide and Cardiomyopathy, Congestive
| Article | Year |
|---|---|
Improvement in Dyssynchrony with Pharmacological Ablation of Right-Sided Accessory Pathway-Induced Cardiomyopathy in Infants.
Topics: Accessory Atrioventricular Bundle; Cardiomyopathy, Dilated; Echocardiography, Doppler; Electrocardio | 2019 |
Impact of serum flecainide level on control of atrial fibrillation in a case treated with cardiac resynchronization therapy.
Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Pacing, Artificial; Cardiomyopathy, Dilat | 2007 |
ST segment elevation induced by class IC antiarrhythmic agents: underlying electrophysiologic mechanisms and insights into drug-induced proarrhythmia.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Cardiomyopathy, Dilated; Electroc | 1998 |
[Anti-arrhythmia agents in heart failure].
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Pacing, Artificial; C | 1992 |
Pseudocardiomyopathy secondary to chronic incessant supraventricular tachycardia.
Topics: Cardiomyopathy, Dilated; Child; Chronic Disease; Flecainide; Humans; Male; Tachycardia, Supraventric | 1989 |